Skip to search formSkip to main contentSkip to account menu

Incyclinide

A chemically-modified tetracycline with potential antineoplastic activity. Incyclinide inhibits matrix metalloproteinases (MMPs), thereby inducing… 
National Institutes of Health

Related topics

Related topics

11 relations
4-dedimethylamino sancyclineAngiogenesis InhibitionCMT-3COL-3

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2009
Review
2009
Use of antibiotics for noninfectious dermatologic disorders.
2009
2009
Schnitzler syndrome: a dramatic improvement with anakinra
© 2008 The Authors JEADV 2009, 23, 70–110 Journal compilation © 2008 European Academy of Dermatology and Venereology The presence… 
2008
2008
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2007
2007
Incyclinide effective at 20 mg dosage
A phase II dose-finding study looking at the safety and therapeutic range of the drug incyclinide (CollaGenex) for the treatment… 
2007
2007
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… 
2007
2007
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data the… 
2007
2007
Incyclinide could clean up for acne
  • 2007
  • Corpus ID: 195108928
2007
2007
CollaGenex Pharmaceuticals has discontinued treatment of all enrolled patients in the 40mg cohort of its Phase II dose-finding study of incyclinide
  • 2007
  • Corpus ID: 195171670
2006
2006
Lower dose of incyclinide effective for Kaposi's sarcoma
  • 2006
  • Corpus ID: 195104140
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)